Episode Details

Moderna’s Co-Founder on the Sprint for a Covid-19 Vaccine

28 Oct 2020

---

Moderna could seek government approval for its Covid-19 vaccine as early as November. We speak with Moderna's co-founder and chairman Noubar Afeyan about the progress they've made, roadblocks they've encountered, and the ethical challenges they may facing in bringing a vaccine to the masses. --------------------------------------------------------------------- At Harvard Business Review, we believe in management. If the world’s organizations and institutions were run more effectively, if our leaders made better decisions, if people worked more productively, we believe that all of us — employees, bosses, customers, our families, and the people our businesses affect — would be better off. So we try to arm our readers with ideas that help them become smarter, more creative, and more courageous in their work. We enlist the foremost experts in a wide range of topics, including career planning, strategy, leadership, work-life balance, negotiations, innovation, and managing teams. Harvard Business Review empowers professionals around the world to lead themselves and their organizations more effectively and to make a positive impact. Sign up for Newsletters: https://hbr.org/email-newsletters Follow us: https://hbr.org/ https://www.linkedin.com/company/harvard-business-review/ https://www.facebook.com/HBR/ https://twitter.com/HarvardBiz https://www.instagram.com/harvard_business_review

Learn more about your ad choices. Visit megaphone.fm/adchoices